Delivery Order SPE2DB20D7061-SPE2DB24FSNG4

Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $2.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,123.20 Firm Fixed Price Delivery Order is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical products. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of REFRESH PLUS 0.5% EYE DROPS 30S. The contract has a ceiling value of $2,717.51 and a completion date of July 22, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has extensive experience in providing pharmaceutical and medical products to various federal...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $2,211.18 contract is for the provision of 4563589797 REFRESH PLUS 0.5% EYE DROPS UD 70S, a pharmaceutical product, to support DLA Troop Support Medical facilities and military treatment programs. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,857.20 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S," a pharmaceutical product, with a period of performance through May 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,499.95, is for the supply of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $6,377.97. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" and has a firm fixed price pricing type. The ultimate completion date is May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,100.81 Firm Fixed Price delivery order is for the supply of 4565166162 REFRESH PLUS 0.5% EYE DROPS UD 50S, with an ultimate completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of critical medical supplies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S". The award, valued at $2,023.45, is a firm fixed-price contract that runs through August 8, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various government agencies, including the DLA, through its extensive federal...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REFRESH PLUS 0.5% EYE DROPS UD 70S. The delivery order, with a potential value of $1,368.90, has a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and does not have any set-aside designation for this contract. This delivery...
This is a $1,083.60 delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC). The contract provides for the delivery of 4565844552 - "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product. The contract has an ultimate completion date of September 18, 2024 and is a Firm Fixed Price arrangement. There is no set-aside designation indicated. Amerisourcebergen is a major supplier of pharmaceutical...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB24FSNG4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $2,719.69 firm fixed price contract is for the delivery of 4564483232 REFRESH PLUS 0.5% EYE DROPS 30S and has an ultimate completion date of May 6, 2024.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is placed against that larger IDC contract vehicle. The contract does not have a set-aside designation.

Generated 8/2/24, 10:09 AM